Deletion of the lipid droplet protein kinase gene affects lipid droplets biogenesis, parasite infectivity, and resistance to trivalent antimony in Leishmania infantum

PLoS Negl Trop Dis. 2024 Jan 18;18(1):e0011880. doi: 10.1371/journal.pntd.0011880. eCollection 2024 Jan.

Abstract

The Lipid Droplet Protein Kinase (LDK) facilitates lipid droplet (LD) biogenesis, organelles involved in various metabolic and signaling functions in trypanosomatids. As LDK's function has not been previously explored in Leishmania spp., we utilized CRISPR/Cas9 technology to generate LDK-knockout lines of Leishmania infantum to investigate its role in this parasite. Our findings demonstrate that LDK is not an essential gene for L. infantum, as its deletion did not impede parasite survival. Furthermore, removing LDK did not impact the growth of promastigote forms of L. infantum lacking LDK. However, a noticeable reduction in LDs occurred during the stationary phase of parasite growth following LDK deletion. In the presence of myriocin, a LD inducer, LDK-knockout parasites displayed reduced LD abundance during both logarithmic and stationary growth phases compared to control parasites. Moreover, an infection analysis involving THP-1 cells revealed that 72 h post-infection, LDK-knockout L. infantum lines exhibited fewer infected macrophages and intracellular amastigotes than control parasites. LDK-knockout L. infantum lines also displayed 1.7 to 1.8 -fold greater resistance to trivalent antimony than control parasites. There were no observed alterations in susceptibility to amphotericin B, miltefosine, or menadione in LDK-knockout L. infantum lines. Our results suggest that LDK plays a crucial role in the biogenesis and/or maintenance of LDs in L. infantum, as well as in parasite infectivity and resistance to trivalent antimony.

MeSH terms

  • Animals
  • Antimony / pharmacology
  • Leishmania infantum* / physiology
  • Lipid Droplets
  • Parasites*
  • Parasitic Diseases*
  • Protein Kinases

Substances

  • Antimony
  • Protein Kinases

Grants and funding

This investigation received financial support from the following agencies: Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG: APQ-02816-21; BPD-00657-22; RED-00104-22; UGA/FAPEMIG APQ-04382-16-D to SMFM), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 304158/2019-4 to SMFM; 152027/2022-0 to JMR; 150691/2023-8 to HMCS), Programa INOVA FIOCRUZ - Fundação Oswaldo Cruz (VPPCB-007-FIO-18-2-94 to SMFM); Convênio Fiocruz-Institut Pasteur-USP (no grant number to SMFM), Programa de Pós-graduação em Ciências da Saúde do Instituto René Rachou/FIOCRUZ (to SMFM) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) (Finance Code 001 to PAS and AMMS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.